Ilumya 100 mg/mL single-dose prefilled syringe Images

Generic Name: tildrakizumab

This medication has been identified as Ilumya 100 mg/mL single-dose prefilled syringe. It is supplied by Sun Pharmaceutical Industries Inc.

Ilumya is used in the treatment of Plaque Psoriasis; Psoriasis and belongs to the drug class interleukin inhibitors. Ilumya 100 mg/mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ilumya

Generic Name

tildrakizumab

Strength

100 mg/mL single-dose prefilled syringe

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sun Pharmaceutical Industries Inc.

National Drug Code (NDC)

47335-0177

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer